WINDTREE THERAPEUTICS INC /DE/ Quarterly Deferred Income Tax Liabilities, Net in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Windtree Therapeutics Inc /De/ quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2018 to Q3 2024.
  • Windtree Therapeutics Inc /De/ Deferred Income Tax Liabilities, Net for the quarter ending September 30, 2024 was $4.89M, a 1.54% increase year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.89M +$74K +1.54% Sep 30, 2024 10-Q 2024-11-26
Q2 2024 $4.77M -$208K -4.18% Jun 30, 2024 10-Q 2024-08-19
Q1 2024 $4.86M -$222K -4.37% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $5.06M -$3K -0.06% Dec 31, 2023 10-Q 2024-11-26
Q3 2023 $4.81M -$1.38M -22.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.98M -$1.66M -25% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $5.08M -$1.8M -26.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $5.06M -$2.05M -28.9% Dec 31, 2022 10-K 2024-04-16
Q3 2022 $6.2M -$2.51M -28.9% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $6.64M -$2.03M -23.4% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $6.89M -$9.8M -58.7% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $7.11M -$9.66M -57.6% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $8.71M -$7.66M -46.8% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $8.67M -$7.46M -46.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $16.7M +$924K +5.86% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $16.8M +$957K +6.05% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $16.4M Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $16.1M Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $15.8M Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $15.8M +$345K +2.23% Dec 31, 2019 10-K 2021-03-29
Q4 2018 $15.5M Dec 31, 2018 10-K 2020-04-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.